H. O’Dowd et al. / Tetrahedron Letters 49 (2008) 2979–2981
2981
Table 1
10a,b are available. Supplementary data associated with
this article can be found, in the online version, at doi:
Yields obtained for analog synthesis via Schemes 1 and 2
References and notes
1. Magerlein, B. J. In Structure–Activity Relationships among the
Semisynthetic Antibiotics; Perlman, D., Ed.; Academic Press: New
York, 1977; pp 601–651.
2. Golebiowski, A.; Jurczak, J. In Recent Progress in the Chemical
Synthesis of Antibiotics; Lukacs, G., Ohno, M., Eds.; Springer: Berlin,
1990; pp 365–385.
R
Entry
c-Propyl
a
i-Propyl
b
c-Pentyl
c
Allyl
d
4-Cl–Ph
e
Yield of 5a (%)
Yield of 9b (%)
a
69
36
74
48
82
39
78
31
81
33
3. Livingston, D. A. Eur. Pat. Appl. EP 0161794, 1985.
4. Lewis, J. G.; Gu, S.; Kumar, S. A.; Chen, T.; O’Dowd, H.; Patel, D.
V.; Hackbarth, C. J.; Asano, R.; Park, C. K.; Blais, J.; Wu, C.; Wang,
W.; Yuan, Z.; Trias, J.; White, R. J.; Gordeev, M. F. ‘Novel
Antimicrobial 7-Methyl Lincosamides: Pipecolamide Analogs’; 44th
Interscience Conference on Antimicrobial Agents and Chemotherapy,
Washington, DC, Oct 30–Nov 2, 2004; F-1389.
Overall yield from nitrone (1?5).
Overall yield from diacetonide (5?9).
b
5. Dondoni, A.; Franco, S.; Junquera, F.; Merchan, F. L.; Merino, P.;
Tejero, T. Synth. Commun. 1994, 24, 2537–2550.
6. Dondoni, A.; Franco, S.; Merchan, F. L.; Merino, P.; Tejero, T.
Synlett 1993, 78–80.
7. Dondoni, A.; Junquera, F.; Merchan, F. L.; Merino, P.; Scherrmann,
M.-C.; Tejero, T. J. Org. Chem. 1997, 62, 5484–5496.
8. Murahashi, S.-I.; Kodera, Y. Tetrahedron Lett. 1985, 26, 4633–4636.
9. Watanabe, T.; Sugawara, S.; Miyadera, T. Chem. Pharm. Bull. 1982,
30, 2579–2582.
10. Knapp, S.; Kukkola, P. J. J. Org. Chem. 1990, 55, 1632–1636.
11. Ibatullin, F. M.; Selivanov, S. I. Tetrahedron Lett. 2002, 43, 9577–
9580.
Scheme 3. Installation of alternative a-thioalkyl groups. Reagents and
conditions: (a) Me2RCSNa, HMPA, DMF, 23 °C; (b) Ac2O, Et3N,
DMAP, CH2Cl2, 23 °C; (c) NaOH aq, MeOH, 23 °C, 58–61% (three
steps).
12. 1H NMR data (300 MHz, CD3OD) 9a: d 5.28 (d, J = 5.7 Hz, 1H),
4.13–4.06 (m, 2H), 3.97 (d, J = 6.6 Hz, 1H), 3.59 (dd, J = 3.3, 9.9 Hz,
1H), 2.33 (dd, J = 6.9, 9.0 Hz, 1H), 2.05 (s, 3H), 0.91–0.77 (m, 1H),
0.58–0.43 (m, 2H), 0.39–0.31 (m, 1H), 0.28–0.19 (m, 1H). Compound
9b: d 5.24 (d, J = 5.7 Hz, 1H), 4.04 (dd, J = 6.0, 10.8 Hz, 1H), 4.02
(dd, J = 1.2, 3.3 Hz, 1H), 3.93 (dd, J = 1.5, 8.7 Hz, 1H), 3.54 (dd,
J = 3.3, 10.5 Hz, 1H), 2.91 (dd, J = 3.6, 8.1 Hz, 1H), 2.08–1.96 (m,
1H), 2.06 (s, 3H), 0.99 (d, J = 6.9 Hz, 3H), 0.88 (d, J = 6.9 Hz, 3H).
Compound 9c: d 5.28 (d, J = 5.7 Hz, 1H), 4.16–4.08 (m, 2H), 3.93 (dd,
J = 0.9, 6.6 Hz, 1H), 3.54 (dd, J = 3.0, 10.2 Hz, 1H), 2.99 (t,
J = 6.6 Hz, 1H), 2.17–2.04 (m, 1H), 2.07 (s, 3H), 1.88–1.51 (m, 6H),
1.42–1.26 (m, 2H). Compound 9d: d 5.94–5.78 (m, 1H), 5.27 (d,
J = 5.7 Hz, 1H), 5.20–5.10 (m, 2H), 4.09 (dd, J = 5.7, 10.2 Hz, 1H),
4.04 (dd, J = 1.5, 3.3 Hz, 1H), 3.82 (dd, J = 0.9, 8.1 Hz, 1H), 3.57 (dd,
J = 3.3, 9.9 Hz, 1H), 3.13 (dt, J = 3.9, 8.4 Hz, 1H), 2.57–2.47 (m, 1H),
2.14–2.02 (m, 1H), 2.07 (s, 3H). Compound 9e: d 7.37 (d, J = 8.4 Hz,
2H), 7.31 (d, J = 9.0 Hz, 2H), 5.09 (d, J = 6.0 Hz, 1H), 4.13–4.03 (m,
4H), 3.58 (dd, J = 3.3, 10.2 Hz, 1H), 1.41 (s, 3H). Compound 10a: d
5.36 (d, J = 6.0 Hz, 1H), 4.05 (dd, J = 5.7, 10.2 Hz, 1H), 4.01 (dd,
J = 1.5, 3.3 Hz, 1H), 3.95 (dd, J = 1.2, 8.7 Hz, 1H), 3.48 (dd, J = 3.3,
10.5 Hz, 1H), 3.04–2.93 (m, 1H), 2.89 (dd, J = 3.6, 8.4 Hz, 1H), 2.07–
1.95 (m, 1H), 1.30 (d, J = 6.9 Hz, 3H), 1.26 (d, J = 6.9 Hz, 3H), 0.98
(d, J = 6.9 Hz, 3H), 0.87 (d, J = 6.6 Hz, 3H). Compound 10b: d 5.39
(d, J = 5.7 Hz, 1H), 4.05 (dd, J = 6.0, 10.8 Hz, 1H), 4.01 (dd, J = 1.2,
3.3 Hz, 1H), 3.90 (dd, J = 1.5, 8.7 Hz, 1H), 3.39 (dd, J = 3.3, 10.5 Hz,
1H), 2.88 (dd, J = 3.6, 8.1 Hz, 1H), 2.08–1.95 (m, 1H), 1.36 (s, 9H),
0.98 (d, J = 6.9 Hz, 3H), 0.89 (d, J = 6.9 Hz, 3H).
such that gram-quantities of the amino sugars 9 are readily
obtained from 5 to 6 g of nitrone 1.
This new route also provides stereoselective access to
additional 1-thioalkyl analogs via the b-chlorogalactose
intermediate 7. The synthesis of tert-butylthio- and isopro-
pylthio-lincosamines (10a,b) is shown in Scheme 3.
In summary, we have developed a novel route to thiolin-
cosamine sugars featuring access to structural diversity at
both the 6- and 1-positions.12 While consisting of several
individual synthetic steps, the basic route requires just
two chromatographic purifications, highlighting the high
average yield-per-step and the excellent stereoselectivity
for the desired isomer. These methods can be employed
to synthesize a variety of novel lincosamides with potential
for antibacterial therapy.
Supplementary data
Detailed experimental procedures for the conversion of
1
1?5a?9a and copies of H NMR spectra for 5a–e, 9a–e,